Keyword: Novasep


Novasep‐PharmaZell Invests €7.3 Million in APIs

27.07.2022 -

Financed in part by the French government’s France Relance plan, Novasep‐PharmaZell is investing €7.3 million in production of active pharmaceuticals (APIs) at its...


Novasep and PharmaZell Conclude Merger

19.04.2022 -

Following exclusive negotiations that started last September, German API specialist PharmaZell and French CDMO Novasep have merged as of Apr. 7. The combined group will...


Novasep Invests in API Capabilities

21.12.2021 -

Novasep, a French CDMO, has announced a €6 million investment to increase and modernize manufacturing capabilities at its Chasse-sur-Rhône site to support new generation...


Novasep and McSAF in ADC Partnership

26.11.2021 -

French CDMO Novasep is collaborating with compatriot biotech McSAF on the preclinical production of Adcitmer, a next-generation antibody drug conjugate (ADC) for treating...


Avid Bioservices Expanding Cell and Gene Therapy

25.10.2021 -

Avid Bioservices, a biologics-oriented CDMO based in the US state of California, is building a new plant in Costa Mesa, California, as part of a plan to expand its cell...


Pharmazell and Novasep in Exclusive Merger Talks

23.09.2021 -

German API specialist PharmaZell and French CDMO Novasep are in exclusive talks about a merger that the companies say would create a leading European platform in the...


Novasep Expands HPAPI Capabilities at Le Mans

18.05.2021 -

French CDMO Novasep is expanding its manufacturing capabilities for highly potent active pharmaceutical ingredients (HPAPIs) at its Le Mans site. The investment of more...


Novasep and Lysogene in Gene Therapy Pact

19.06.2020 - French contract services firm Novasep has signed an agreement with compatriot biopharma Lysogene to develop and manufacture LYS-GM101, the latter’s Adeno-Associated Virus (AAV)rh10...